Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study
Article in RMD Open (February 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in RMD Open (February 2024)
Article in BioDrugs (November 2023)
Article in Expert Opinion on Investigational Drugs (May 2023)